Effects of the synthesized growth hormone releasing peptide, KP-102, on growth hormone release in sodium glutamate monohydrate-treated low growth rats

Life Sciences

Volumn 59, Issue 9, 1996, Pages 705-712

  Nakagawa, Terutake ^a   Ukai, Kiyoharu ^a   Ohyama, Tadashi ^a   Koida, Masao ^b   Okamura, Hitoshi ^c  

^a KAKEN PHARMACEUTICAL CO LTD   (Japan)

^b SETSUNAN UNIVERSITY   (Japan)

^c KOBE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

arcuate nuclei lesion; growth hormone releasing peptide; i.c.v.; KP 102

Indexed keywords

GLUTAMATE SODIUM; GROWTH HORMONE RELEASING FACTOR; PENTOBARBITAL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARCUATE NUCLEUS; ARTICLE; BODY GROWTH; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG SYNTHESIS; FEMALE; GROWTH HORMONE DEFICIENCY; GROWTH HORMONE RELEASE; GROWTH REGULATION; HORMONE ACTION; HYPOTHALAMUS HYPOPHYSIS SYSTEM; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; RAT;

ANIMALIA;

EID: 0030602806     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/0024-3205(96)00356-6     Document Type: Article

References (20)

1. 1. C.Y. BOWERS, F. MOMANY, G.A. REYNOLDS, D. CHANG, A. HONG and K. CHANG, Endocrinology 106 663-667 (1980).
2. 2. C.Y. BOWRS, F. MOMANY, G.A. REYNOLDS and A. HONG, Endocrinology 114 1537-1545 (1984).
3. 3. O. SHIMADA, T. OKUNO, T. KIYOFUZI, T. MARUYAMA, S. KURASAKI, K. CHIHARA and C.Y. BOWERS, International Symposium on Growth Hormone Secretagogues, Florida, Serono Symposia, USA, 45 (1994).
4. 4. D. WU, C. CHEN, K. KATOH, J. ZHANG and I.J. CLARKE, J. Endocrinol. 140 9-13 (1994).
5. 5. T.P. FLETCHER, G.B. THOMAS, J.O. WILLOUGHBY and I.J. CLARKE, Neuroendocrinology 60 76-86 (1994).
6. 6. F. MALLO, C.V. ALVAREZ, L. BENITEZ, B. BURGUERA, R. COYA, F.F. CASANUEVA and C. DIEGUEZ, Neuroendoclinology 57 247-256 (1993).
7. 7. V. POPOVIC, S. DAMJANOVIC, D. MICIC, M. DJUROVIC, C. DIEGUEZ, F.F. CASANUEVA and J. CLIN. Endocrinol. Metab. 80 942-947 (1995).
8. 8. W.R. SCHOEN, M.J. WYVRATT and R.G. SMITH, Growth hormone secretagogues. In Annual Reports in Medical Chemistry, J.A. Bristol(ED), Chapter 19, Academic Press, San Diego CA, 28 (1993).
9. 9. W.J. MILLARD, J.B. MARTIN, S.M. AUDET, S.M. SAGAR and J.B. MARTIN, Endocrinology 111 540-550 (1982).
10. 10. L.C. TERRY, J. EPELBAUM and J.B. MARTIN, Brain Reserch 217 129-142 (1981).
11. 11. G. TAGUCHI, System of experimental design. American Supplier Institute, INC.(Michigan), Unequal numbers of repetitions 36-40 (1987).
12. 12. T.C. CHOU and P. TALALAY, TIPS 450-454 (1983).
13. 13. K.M. FAIRHALL, A. MYNETT and I.C.A.F. ROBINSON, J. Endocrinology 144 555-560 (1995)
14. 14. S.L. DICKSON, G. LENG and C.A.F. ROBINSON, Neuroscience 53, 303-306 (1993)
15. 15. J. KAMEGAI, H. SUGIHARA, MINAMI and I. WAKABAYASHI, Proceedings of the 77th Annual Meeting of the American Endocrine Society, Washington, DC 502P (1995).
16. 16. C.Y. BOWERS, A.O. SARTOR, G.A. REYNOLDS and T.M. BADGER, Endocrinology 128 2027-2035 (1991).
17. 17. P.M. PLOTSKY and W. VALE, Science 230 461-463 (1985).
18. 18. V. GUILLAUME, E. MAGNAN, M. CATADI, A. DUTOUR, N. SAUZE, B. CONTE-DOVOLX, C. OLIVER, V. LENERTS and R. DEGENGHI, Proceedings of the 76th Annual Meeting of the American Endocrine Society, Anaheim 657P (1994).
19. 19. H. SAWADA, H. SUGIHARA, H. ONOSE, S. MINAMI, T. SHIBASAKI and I. WAKABAYASHI, Regul. Pept. 53 195-201 (1994).
20. 20. P. MARTUL, J. PINEDA, M. POMBO, A. PENALVA, L. BOKSER and C. DIEGUEZ, J. Pediatr. Endocrinol. 6 317-323 (1993).